In Client successes

Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes

Congratulations to Ammira-Sarah Akil and colleagues at Sidra Medicine on the publication of their latest review in Cells (MDPI)! In their article, Akil et al. outline the key epigenetic modifications associated with type 1 diabetes pathogenesis. They then speculate on how we might harness such epigenetic mechanisms to develop novel therapeutics.

To learn more about this fascinating topic, this review is available open access via the following link: